197 related articles for article (PubMed ID: 24568519)
1. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.
Zhu Z; Wang CP; Zhang YF; Nie L
Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Src by microRNA-23b increases the cisplatin sensitivity of chondrosarcoma cells.
Huang K; Chen J; Yang MS; Tang YJ; Pan F
Cancer Biomark; 2017; 18(3):231-239. PubMed ID: 28085008
[TBL] [Abstract][Full Text] [Related]
3. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
[TBL] [Abstract][Full Text] [Related]
4. miR-100 resensitizes resistant epithelial ovarian cancer to cisplatin.
Guo P; Xiong X; Zhang S; Peng D
Oncol Rep; 2016 Dec; 36(6):3552-3558. PubMed ID: 27748936
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
Wu D; Huang HJ; He CN; Wang KY
Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
[TBL] [Abstract][Full Text] [Related]
6. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
Chen W; Yang Y; Chen B; Lu P; Zhan L; Yu Q; Cao K; Li Q
J Neurooncol; 2014 Oct; 120(1):43-53. PubMed ID: 25139024
[TBL] [Abstract][Full Text] [Related]
7. miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism.
Tang XY; Zheng W; Ding M; Guo KJ; Yuan F; Feng H; Deng B; Sun W; Hou Y; Gao L
Drug Des Devel Ther; 2016; 10():571-83. PubMed ID: 26966351
[TBL] [Abstract][Full Text] [Related]
8. Roles of microRNA-22 in Suppressing Proliferation and Promoting Sensitivity of Osteosarcoma Cells via Metadherin-mediated Autophagy.
Wang P; Zhao ZQ; Guo SB; Yang TY; Chang ZQ; Li DH; Zhao W; Wang YX; Sun C; Wang Y; Feng W
Orthop Surg; 2019 Apr; 11(2):285-293. PubMed ID: 30932352
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide inhibits growth of human chondrosarcoma cells through G2/M arrest and apoptosis as well as autophagy.
Jiao G; Ren T; Guo W; Ren C; Yang K
Tumour Biol; 2015 May; 36(5):3969-77. PubMed ID: 25577250
[TBL] [Abstract][Full Text] [Related]
10. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR.
Yu Z; Li N; Jiang K; Zhang N; Yao LL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5867-5873. PubMed ID: 30280766
[TBL] [Abstract][Full Text] [Related]
11. MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells by inhibiting mTOR signaling pathway and expression of MDR1.
Li Q; Xia X; Ji J; Ma J; Tao L; Mo L; Chen W
Oncotarget; 2017 May; 8(20):33621-33630. PubMed ID: 28422725
[TBL] [Abstract][Full Text] [Related]
12. MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1.
Xu S; Fu GB; Tao Z; OuYang J; Kong F; Jiang BH; Wan X; Chen K
Oncotarget; 2015 Sep; 6(28):26457-71. PubMed ID: 26238185
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
14. CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells.
Liu GT; Huang YL; Tzeng HE; Tsai CH; Wang SW; Tang CH
Cancer Lett; 2015 Feb; 357(2):476-87. PubMed ID: 25444917
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
Zhang B; Zhao R; He Y; Fu X; Fu L; Zhu Z; Fu L; Dong JT
Oncotarget; 2016 Feb; 7(5):5702-14. PubMed ID: 26744318
[TBL] [Abstract][Full Text] [Related]
16. Tumor Suppressive Role of miR-342-5p in Human Chondrosarcoma Cells and 3D Organoids.
Veys C; Benmoussa A; Contentin R; Duchemin A; Brotin E; Lafont JE; Saintigny Y; Poulain L; Denoyelle C; Demoor M; Legendre F; Galéra P
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070455
[TBL] [Abstract][Full Text] [Related]
17. microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer.
Wu K; Hu Y; Yan K; Qi Y; Zhang C; Zhu D; Liu D; Zhao S
J Cell Physiol; 2020 Feb; 235(2):1247-1258. PubMed ID: 31267531
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.
Lin Z; Song D; Wei H; Yang X; Liu T; Yan W; Xiao J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):239-46. PubMed ID: 26276504
[TBL] [Abstract][Full Text] [Related]
19. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
Farhadi E; Zaker F; Safa M; Rezvani MR
Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565
[TBL] [Abstract][Full Text] [Related]
20. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]